Key facts
- This page summarizes John E. Lynch's Form 4 filing for India Globalization Capital, Inc. (IGC).
- 5 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 28 Jun 2022, 20:24.
John E. Lynch - 31 May 2022 Form 4 Insider Report for India Globalization Capital, Inc. (IGC)
- Reporting relationship
- Director
- Issuer ticker
- IGC
- Reported as of
- 31 May 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 28 Jun 2022, 20:24:35 UTC
- Prior SEC filing
- 04 Jun 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ John E. Lynch
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
John E. Lynch filed Form 4 for India Globalization Capital, Inc. (IGC) on 28 Jun 2022.
Change
- Previous filing in this sequence was filed on 04 Jun 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IGC
transaction
COMMON STOCK
Options Exercise
- Transaction value
- $0
- Shares
- +28,125
- Change %
- +29%
- Price
- $0.000000
- Shares after
- 125,026
- Date
- 31 May 2022
- Ownership
- Direct
- Footnotes
- F1
IGC
transaction
COMMON STOCK
Options Exercise
- Transaction value
- $0
- Shares
- +9,375
- Change %
- +7.5%
- Price
- $0.000000
- Shares after
- 134,401
- Date
- 01 Jun 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IGC
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +150,000
- Change %
- +100%
- Price
- $0.000000
- Shares after
- 300,000
- Date
- 20 Dec 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 150,000
- Exercise price
- $0.000000
- Footnotes
- F1
IGC
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -28,125
- Change %
- -9.4%
- Price
- $0.000000
- Shares after
- 271,875
- Date
- 31 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 28,125
- Exercise price
- $0.000000
- Footnotes
- F1
IGC
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -9,375
- Change %
- -3.4%
- Price
- $0.000000
- Shares after
- 262,500
- Date
- 01 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,375
- Exercise price
- $0.000000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
On December 20, 2021, the Reporting Person was granted RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. The RSUs vest when milestones are achieved. On May 31 and June 1, 2022, two of the milestones related to our IGC-AD1 clinical trials were reached.